13.06
-0.02(-0.15%)
Currency In USD
Address
300 5th Avenue
Waltham, MA 02451
United States of America
Phone
617-430-5595
Sector
Healthcare
Industry
Biotechnology
Employees
33
First IPO Date
January 10, 2014
| Name | Title | Pay | Year Born |
| Mr. Joshua T. Brumm | Chief Executive Officer & Director | 0 | 1978 |
| Mr. Ryan Lynch | Senior Vice President of Finance, Treasurer & Chief Accounting Officer | 0 | 1984 |
| Dr. Ellie Im M.D. | Chief Medical Officer | 0 | 1978 |
| Mr. Richard William Scalzo M.B.A. | Chief Financial Officer | 0 | 1986 |
| Ms. Barbara H. Bispham J.D. | General Counsel & Corporate Secretary | 0 | 1986 |
| Dr. Wenjie Cheng Ph.D. | Senior Vice President of Technical Operations | 0 | N/A |
| Dr. Jan Pinkas Ph.D. | Chief Scientific Officer | 0 | N/A |
| Mr. Christopher Doughty | Chief Business Officer | 0 | 1987 |
| Dr. Jonathan McNeill M.D. | President & Chief Operating Officer | 0 | 1985 |
| Ms. Amy Reilly | Chief Communications Officer | 0 | 1973 |
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.